Abstract
This review discusses the mineral bone disorders in patients with chronic kidney disease. We focus on the management of these conditions by administration of calcium, vitamin D (ergocalciferol and cholecalciferol), vitamin D receptor activators (calcitriol, alphacalcidiol), phosphate binders and calcimimetics (cinacalcet).
| Translated title of the contribution | Treatment of mineral bone disorder with pharmaceuticals which influence the calcium phosphor turnover |
|---|---|
| Original language | Danish |
| Journal | Ugeskrift for Laeger |
| Volume | 174 |
| Issue number | 47 |
| Pages (from-to) | 2931-4 |
| Number of pages | 4 |
| ISSN | 0041-5782 |
| Publication status | Published - 2012 |
Fingerprint
Dive into the research topics of 'Treatment of mineral bone disorder with pharmaceuticals which influence the calcium phosphor turnover'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS